EX-23.3
Published on August 30, 2013
EXHIBIT 23.3
The Board of Directors of OPKO Health, Inc.
We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated December 20, 2012 with respect to the consolidated financial statements of Cytochroma Canada Inc. included in the Current Report on Form 8-K/A of OPKO Health, Inc. filed with the Securities and Exchange Commission on May 3, 2013.
/s/ KPMG LLP
Chartered Accountants, Licensed Public Accountants
Toronto, Canada
August 29, 2013